Holles Natalie C.
Transactions
50
Companies
8
Filings
5
CIK
0001580111
Recent Transactions
- Award
- Award
- Award
- Award
- Award
- Disposition to Issuer
- Disposition to Issuer
Stock Option (right to buy Common Stock)
2026-04-23−40,000→ 0 total - Disposition to Issuer
Stock Option (right to buy Common Stock)
2026-04-23−40,300→ 0 total - Disposition to Issuer
Stock Option (right to buy Common Stock)
2026-04-23−28,700→ 0 total - Disposition to Issuer
Stock Option (right to buy Common Stock)
2026-04-23−37,500→ 0 total - Disposition to Issuer
Stock Option (right to buy Common Stock)
2026-04-23−32,335→ 0 total - Disposition to Issuer
Stock Option (right to buy Common Stock)
2026-04-23−22,500→ 0 total - Disposition to Issuer
- Disposition to Issuer
Stock Option (right to buy Common Stock)
2025-11-06−40,000→ 0 total - Disposition to Issuer
Stock Option (right to buy Common Stock)
2025-11-06−40,300→ 0 total - Award
Stock Option (right to buy Common Stock)
2025-11-06+28,700→ 28,700 total - Award
Stock Option (right to buy Common Stock)
2025-11-06+40,300→ 40,300 total - Award
Stock Option (right to buy Common Stock)
2025-11-06+40,000→ 40,000 total - Disposition to Issuer
Stock Option (right to buy Common Stock)
2025-11-06−28,700→ 0 total - Disposition to Issuer
Stock Option (right to buy Common Stock)
2025-11-06−37,500→ 0 total - Award
Stock Option (right to buy Common Stock)
2025-11-06+37,500→ 37,500 total - Disposition to Issuer
Stock Option (right to buy Common Stock)
2025-11-06−32,335→ 0 total - Award
Stock Option (right to buy Common Stock)
2025-11-06+32,335→ 32,335 total - Other
- Other
- Other
- Award
Stock Option (right to buy Common Stock)
2025-06-02+22,500→ 22,500 total - Award
Deferred Restricted Stock Unit (RSU)
2025-06-02+15,000→ 15,000 total - Award
- Award
- Award
Stock Option (right to buy Common Stock)
2024-05-23+32,335→ 32,335 total - Exercise/Conversion
- Sale
- Exercise/Conversion
- Sale
- Exercise/Conversion
- Exercise/Conversion
- Award
- Award
- Award
Director Stock Option (Right to buy Common Stock)
2023-06-22+37,500→ 37,500 total - Disposition to Issuer
- Award
- Award
- Award
- Disposition to Issuer
- Award
- Award
Director Stock Option (Right to buy Common Stock)
2022-06-21+28,700→ 28,700 total - Award
- Award
- Award
Companies
8Allakos Inc.
Director
Audentes Therapeutics, Inc.
Senior Vice President, COO
- $AURA
Aura Biosciences, Inc.
Director, See Remarks
- $DAWN
Day One Biopharmaceuticals, Inc.
Director
HYPERION THERAPEUTICS INC
SVP, Corp & Business Dev
- $LONA
LeonaBio, Inc.
Director
Rubius Therapeutics, Inc.
Director
Third Harmonic Bio, Inc.
Director, CEO
Recent Filings
5Address
C/O LEONABIO, INC. 18706 NORTH CREEK PARKWAY, SUITE 104
BOTHELL, WA, 98011